US Patent 11925651 TEAD inhibitors and uses thereof
Patent 11925651 was granted and assigned to Ikena Oncology on March, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11925651 TEAD inhibitors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
